Advancing the search for antibodies to treat Alzheimer’s disease

Two new studies illustrate that not all forms of amyloid-beta protein — the protein thought to initiate Alzheimer’s disease — play an equally menacing role in the progress of the disease. Using a new way of preparing and extracting the protein as well as a new technique to search for promising drug candidates, researchers have highlighted the importance of testing and targeting different forms of amyloid-beta.

Source: sciencedaily.com